PATENT CLAIM ANALYSIS

Application Number: 15760199
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["548", "400000"]

Abstract:
Small molecules comprised of azacyclic constrained sphingolipid-like compounds and methods of their synthesis are provided. Formulations and medicaments are also provided that are directed to the treatment of disease, such as, for example, neoplasms, cancers, and other diseases. Therapeutics are also provided containing a therapeutically effective dose of one or more small molecule compounds, present either as pharmaceutically effective salt or in pure form, including, but not limited to, formulations for oral, intravenous, or intramuscular administration.

Claim (Index 23):
The medicament of  claim 12  further comprising at least one FDA-approved compound for the treatment of a neoplasm.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 90.0
- Lexical Diversity: 1.5
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14903579', '11666518', '12673799', '13430555', '11666519']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6721309902300342
- 35 USC 102 Novelty (BERT): 0.5627674978510371
- Combined Prediction Score: 0.6611946409921344
- Mean Citation Score: 242.16575200000003
- Max Citation Score: 429.8919
- Similarity Product: 233.9597032508254

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test